<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001701247</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001672619</issuerCik>
      <issuerName>Enliven Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39247</secFileNumber>
      <issuerAddress>
        <com:street1>6200 LOOKOUT ROAD</com:street1>
        <com:city>BOULDER</com:city>
        <com:stateOrCountry>CO</com:stateOrCountry>
        <com:zipCode>80301</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>720-647-8519</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Collins Helen Louise</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave</com:street1>
          <com:street2>4th Fl</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>15000</noOfUnitsSold>
      <aggregateMarketValue>620100.00</aggregateMarketValue>
      <noOfUnitsOutstanding>61000000</noOfUnitsOutstanding>
      <approxSaleDate>05/18/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/09/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>15000</amountOfSecuritiesAcquired>
      <paymentDate>08/09/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>02/17/2026</saleDate>
      <amountOfSecuritiesSold>45000</amountOfSecuritiesSold>
      <grossProceeds>1177863.50</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>03/09/2026</saleDate>
      <amountOfSecuritiesSold>29871</amountOfSecuritiesSold>
      <grossProceeds>896809.86</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>03/10/2026</saleDate>
      <amountOfSecuritiesSold>10129</amountOfSecuritiesSold>
      <grossProceeds>305826.52</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>03/17/2026</saleDate>
      <amountOfSecuritiesSold>5000</amountOfSecuritiesSold>
      <grossProceeds>138799.90</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>03/25/2026</saleDate>
      <amountOfSecuritiesSold>40000</amountOfSecuritiesSold>
      <grossProceeds>1404022.40</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Helen Collins</name>
        <address>
          <com:street1>6200 Lookout Road</com:street1>
          <com:street2>First Floor</com:street2>
          <com:city>Boulder</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80301</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Enliven Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>04/17/2026</saleDate>
      <amountOfSecuritiesSold>5000</amountOfSecuritiesSold>
      <grossProceeds>238352.40</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 10/19/2025, and all representations regarding material non-public information were made as of the adoption of the plan.</remarks>
    <noticeSignature>
      <noticeDate>05/18/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>10/19/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Helen Collins</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
